GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » 3-Year EBITDA Growth Rate

BioPharma Credit (LSE:BPCR) 3-Year EBITDA Growth Rate


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit 3-Year EBITDA Growth Rate?

3-Year EBITDA Growth Rate does not apply to banks.


BioPharma Credit Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.